Key facts
| Price (PPV) | 102.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | fénotérolipratropium |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03AL01 |
| Manufacturer | BOTTU S.A. |
| Presentation | Flacon de 200 doses |
| Hospital price | 64.30 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement symptomatique de la crise d'asthme. Traitement symptomatique des exacerbations au cours de la maladie asthmatique ou de la bronchite chronique obstructive lorsqu'il existe une composante réversible. Prévention de l'asthme d'effort. Traitement symptomatique continu du bronchospasme réversible de la bronchopneumopathie chronique obstructive (BPCO), lorsqu'un seul bronchodilatateur n'est pas suffisant.
Find an open pharmacy
On-call pharmacies near you
About Bronchodual 50 µg / 20 µg Par Dose
Bronchodual 50 µg / 20 µg Par Dose belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Bronchodual 50 µg / 20 µg Par Dose, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Bronchodual 50 µg / 20 µg Par Dose
Answers to common questions from Moroccan patients about this drug.